Genome-wide
DNA hypomethylation plays an important role in epigenomic and
genomic instability and colorectal
carcinogenesis. DNA methylation in the long interspersed
nucleotide element-1, L1 (LINE-1) repetitive
element is a good
indicator of global DNA methylation level. In addition, LINE-1 hypomethylation in blood cells has been associated with colorectal
adenoma risk, and LINE-1 hypomethylation in
colorectal cancer is related with prognosis and linearly predicts shorter patient survival. However, no study has comprehensively evaluated the precision of
sodium bisulfite conversion and PCR-pyrosequencing to measure LINE-1 methylation. Using 10
paraffin-embedded
colon cancers, 5 matched normal colon mucosa, and 5 unrelated peripheral blood buffy coat leukocyte specimens, we enriched
tumor DNA by macrodissection and
laser capture microdissection. LINE-1 methylation was calculated as an average of 100 * C/(C + T) at 4 CpG sites after
bisulfite-PCR-pyrosequencing. The LINE-1 methylation value in
colon cancers varied, ranging approximately from 30 to 80. To measure assay precision, we performed
bisulfite conversion on seven different
DNA specimen aliquots and repeated PCR-pyrosequencing seven times. Run-to-run (between-run) SD ranged from 1.3 to 4.4 (median, 3.0) in macrodissected
colon cancers; 1.1 to 10.5 (median, 3.8) in
laser capture microdissection specimens; 1.3 to 2.5 (median, 1.9) in normal colon; and 1.5 to 3.4 (median, 1.9) in leukocyte
DNA. In conclusion,
bisulfite conversion and PCR-pyrosequencing assay can measure LINE-1 methylation in macrodissected
colon cancer, normal colon, and blood
DNA, and may be useful in clinical and research settings.